TNF and Alzheimer disease: For instance, galantamine, as a common clinical cholinergic agent for improving cognitive function in elderly Alzheimer’s patients, is found to effectively suppress the secretion of pro-inflammatory cytokines like TNF-α and IL-1β, indicating the indispensable role of anti-neuroinflammatory therapy in AD (14).